Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Myocardial Bridging: Definition, Clinical Significance, and Management

Anatomic Features and Pathophysiology

  • The left anterior descending artery is affected in almost all cases of myocardial bridging, making it the predominant location for this anatomic variant 1
  • The reported incidence of myocardial bridging varies dramatically between detection methods: 0.5-4.5% on angiography versus 15-85% at autopsy, indicating that most bridges are clinically silent and only detected incidentally 1
  • The characteristic angiographic finding is systolic compression of the artery during the cardiac cycle, which distinguishes it from atherosclerotic disease that typically causes fixed stenosis 1
  • Vessel narrowing occurs due to transient myocardial compression during systole, and quantitative coronary angiography demonstrates delayed and incomplete vessel diameter recovery during mid-to-late diastole in symptomatic patients 1

Clinical Significance and Risk Stratification

  • Myocardial bridges occur in 30-50% of patients with hypertrophic cardiomyopathy and have been implicated as a possible cause of sudden cardiac death in this population 1, 2
  • Although most myocardial bridges are benign, they can cause myocardial ischemia, myocardial infarction, malignant ventricular arrhythmias, atrioventricular block, and sudden cardiac death in select cases 1

Management Approach

  • Beta-blockers are the first-line treatment for symptomatic myocardial bridging, as they reduce heart rate and myocardial contractility, decreasing systolic compression and prolonging diastole for improved coronary perfusion 1, 2
  • Nitrates are contraindicated because they paradoxically increase angiographic systolic narrowing and worsen symptoms by increasing myocardial contractility 1, 2
  • Functional assessment is critical: ECG exercise testing, dobutamine stress echocardiography, or myocardial perfusion scintigraphy should be performed to evaluate for inducible ischemia 1, 2

Evidence‑Based Facts on Myocardial Bridge

Definition

  • A myocardial bridge is a congenital coronary anomaly in which a segment of an epicardial coronary artery runs intramyocardially and is compressed during systole, producing a dynamic stenosis 3.

Anatomical Risk Factors

  • Pathological studies show that tunneled arterial segments that are deeper than ≈3 mm beneath the epicardium and longer than ≈3 mm are associated with the highest risk of adverse cardiac events 3.

Epidemiology in Hypertrophic Cardiomyopathy

  • Myocardial bridging is present in roughly 30–50 % of individuals with hypertrophic cardiomyopathy and has been implicated as a possible contributor to sudden cardiac death in this population 4.

Pathophysiology of Ischemia

  • The primary mechanism of ischemia is impaired coronary blood flow caused by systolic compression that may extend into diastole, leading to a supply‑demand mismatch and potential myocardial injury 4.